Skip to main content
ARTELO BIOSCIENCES, INC. logo

ARTELO BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · ARTL ISIN · US04301G7060 US Manufacturing
Filings indexed 425 across all filing types
Latest filing 2017-01-10 Interim / Quarterly Rep…
Country US United States of America
Listing US ARTL

About ARTELO BIOSCIENCES, INC.

https://artelobio.com/

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics. The company's scientific approach is centered on modifying lipid-signaling pathways, particularly by modulating the endocannabinoid system. Its primary therapeutic focus is on developing improved treatments for patients with cancer and other serious diseases. Artelo is advancing a diverse portfolio of drug candidates through its development pipeline to address unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q1 2017
2017-01-10 English
FORM 10-K/A
Annual Report FY 2016
2016-12-01 English
FORM 10-K
Annual Report FY 2016
2016-11-29 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes an entry into a material definitive agreement (a senior promissory note), a change in control of the registrant, and the departure and appointment of directors and officers. These are typical disclosures in an 8-K filing. The document does not contain full financial statements or detailed financial performance data, so it is not an Annual Report (10-K) or Interim Report (IR). It also does not fit into categories like Earnings Release or Proxy Solicitation. The primary focus is on management changes and material agreements. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements including Form 8-K filings that do not fit other categories.
2016-11-18 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content specifically discusses the termination of a material definitive agreement related to a merger transaction. It does not contain financial statements or detailed financial analysis, nor is it an earnings release or annual report. The document is an announcement of a corporate event (termination of a merger agreement). According to the filing definitions, this fits best under 'Regulatory Filings' (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories. The document length is short and it is not a report publication announcement or certification. Therefore, the classification is RNS with high confidence.
2016-09-07 English
FORM 8-K
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 12, 2016, reporting the entry into a material definitive agreement—a binding letter of intent for a reverse triangular merger between Knight Knox Development Corp. and GiftBoxCenter, LLC. The content focuses on merger-related details, conditions, and agreements. There are no financial statements or earnings data presented, nor is this a proxy or voting result announcement. The document is clearly about a merger transaction announcement. According to the filing definitions, announcements and documents related to merger proposals or takeover bids fall under the category 'M&A Activity' (Code: TAR). The document length is 4118 characters, which is sufficient to contain substantive information about the merger agreement rather than just a brief announcement or report publication. Therefore, the correct classification is 'TAR' with high confidence.
2016-07-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.